Neuroimmunecorrective therapy in stroke patients with herpetic complications

  • A. E. Kulchikov Institute of Neurosurgery named acad. N.N. Burdenko RAMS, Moscow, Russian Federation
  • S. G. Morozov Institute of Neurosurgery named acad. N.N. Burdenko RAMS, Moscow, Russian Federation
  • E. A. Grinenko Institute of Neurosurgery named acad. N.N. Burdenko RAMS, Moscow, Russian Federation
Keywords: latent herpes infection contaminations reactivation, immunopathological dates, an acute ischemic stroke, Cerebrolysin

Abstract

The results of conducted study have shown that the patients with an acute ischemic stroke had the reactivation of the la tent herpes infection against immunodeficiency (HSV DNA in blood of pa tients). Cerebrolysin® («Ever neuro pharma», Austria) at patients with stroke-induced herpes infection contamfnation leads to the accelerated regeneration of the disturbed neurological functions, normalization of immune system dates and treated of a peripheral blood by 10th day of disease with authentic differences (p<0,01).

Published
2023-06-02
How to Cite
Kulchikov, A. E., Morozov, S. G., & Grinenko, E. A. (2023). Neuroimmunecorrective therapy in stroke patients with herpetic complications. Patogenez (Pathogenesis), 10(1), 57-61. Retrieved from https://pathogenesis.pro/index.php/pathogenesis/article/view/726
Issue
Vol. 10 No. 1 (2012): Патогенез
Section
Original investigations